全文获取类型
收费全文 | 35864篇 |
免费 | 2197篇 |
国内免费 | 103篇 |
专业分类
耳鼻咽喉 | 331篇 |
儿科学 | 1090篇 |
妇产科学 | 896篇 |
基础医学 | 5064篇 |
口腔科学 | 680篇 |
临床医学 | 4249篇 |
内科学 | 7473篇 |
皮肤病学 | 778篇 |
神经病学 | 3425篇 |
特种医学 | 767篇 |
外科学 | 3578篇 |
综合类 | 280篇 |
一般理论 | 27篇 |
预防医学 | 3985篇 |
眼科学 | 630篇 |
药学 | 2510篇 |
1篇 | |
中国医学 | 120篇 |
肿瘤学 | 2280篇 |
出版年
2023年 | 259篇 |
2022年 | 328篇 |
2021年 | 900篇 |
2020年 | 574篇 |
2019年 | 910篇 |
2018年 | 1207篇 |
2017年 | 778篇 |
2016年 | 853篇 |
2015年 | 999篇 |
2014年 | 1182篇 |
2013年 | 1833篇 |
2012年 | 2646篇 |
2011年 | 2892篇 |
2010年 | 1503篇 |
2009年 | 1309篇 |
2008年 | 2356篇 |
2007年 | 2443篇 |
2006年 | 2459篇 |
2005年 | 2304篇 |
2004年 | 2158篇 |
2003年 | 1994篇 |
2002年 | 1760篇 |
2001年 | 526篇 |
2000年 | 572篇 |
1999年 | 481篇 |
1998年 | 266篇 |
1997年 | 203篇 |
1996年 | 184篇 |
1995年 | 131篇 |
1994年 | 147篇 |
1993年 | 128篇 |
1992年 | 176篇 |
1991年 | 177篇 |
1990年 | 164篇 |
1989年 | 146篇 |
1988年 | 102篇 |
1987年 | 106篇 |
1986年 | 109篇 |
1985年 | 94篇 |
1984年 | 91篇 |
1983年 | 97篇 |
1982年 | 80篇 |
1981年 | 59篇 |
1980年 | 64篇 |
1979年 | 49篇 |
1978年 | 39篇 |
1977年 | 37篇 |
1976年 | 38篇 |
1974年 | 35篇 |
1973年 | 30篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Engel K Vuissoz JM Eggimann S Groux M Berning C Hu L Klaus V Moeslinger D Mercimek-Mahmutoglu S Stöckler S Wermuth B Häberle J Nuoffer JM 《Journal of inherited metabolic disease》2012,35(1):133-140
Background
The urea cycle defect argininosuccinate lyase (ASL) deficiency has a large spectrum of presentations from highly severe to asymptomatic. Enzyme activity assays in red blood cells or fibroblasts, although diagnostic of the deficiency, fail to discriminate between severe, mild or asymptomatic cases. Mutation/phenotype correlation studies are needed to characterize the effects of individual mutations on the activity of the enzyme.Methods
Bacterial in-vitro expression studies allowed the enzyme analysis of purified mutant ASL proteins p.I100T (c.299?T?>?C), p.V178M (c.532?G?>?A), p.E189G (c.566A?>?G), p.Q286R (c.857A?>?G), p.K315E (c.943A?>?G), p.R379C (c.1135?C?>?T) and p.R385C (c.1153?C?>?T) in comparison to the wildtype protein.Results
In the bacterial in-vitro expression system, ASL wild-type protein was successfully expressed. The known classical p.Q286R, the novel classical p.K315E and the known mutations p.I100T, p.E189G and p.R385C, which all have been linked to a mild phenotype, showed no significant residual activity. There was some enzyme activity detected with the p.V178M (5 % of wild-type) and p.R379C (10 % of wild-type) mutations in which Km values for argininosuccinic acid differed significantly from the wild-type ASL protein.Conclusion
The bacterially expressed enzymes proved that the mutations found in patients and studied here indeed are detrimental. However, as in the case of red cell ASL activity assays, some mutations found in genetically homozygous patients with mild presentations resulted in virtual loss of enzyme activity in the bacterial system, suggesting a more protective environment for the mutant enzyme in the liver than in the heterologous expression system and/or in the highly dilute assays utilized here. 相似文献992.
993.
994.
995.
996.
997.
998.
BackgroundPeripheral artery disease (PAD) screening may be performed to prevent progression of PAD or future cardiovascular disease in general. Recommendations for PAD screening have to be derived indirectly because no randomized trials comparing screening versus no screening have been performed. We performed a systematic review of guidelines to evaluate the value of PAD screening in asymptomatic adults.MethodsGuidelines in English published between January 1, 2003 and January 20, 2011 were retrieved using MEDLINE, CINAHL, the National Guideline Clearinghouse, the National Library for Health, the Canadian Medication Association Infobase, and the G-I-N International Guideline Library. Guidelines developed by national and international medical societies from Western countries, containing recommendations on PAD screening, were included. Two reviewers independently assessed rigor of guideline development using the Appraisal of Guidelines Research and Evaluation (AGREE) instrument. One reviewer performed full extraction of recommendations, which was validated by a second reviewer.ResultsOf 2779 titles identified, 8 guidelines were included. AGREE scores varied from 33% to 81%. Five guidelines advocated PAD screening, others found insufficient evidence for PAD screening or were against it. Measurement of the ankle-brachial index (ABI) was generally recommended for middle-aged populations with elevated cardiovascular risk levels. Those identified as having PAD are reclassified as high risk, warranting intensive preventive interventions to reduce their risk of a cardiovascular event. The underlying evidence mainly consisted of studies performed in patients with established PAD. A meta-analysis that evaluated ABI testing in the context of traditional cardiovascular risk assessment was interpreted differently.ConclusionsRecommendations on PAD screening vary across current guidelines, making the value of PAD screening uncertain. The variation seems to reflect lack of studies that show added value of detection of early PAD beyond expectant management and traditional risk assessment. 相似文献
999.